ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Congress Provides 7% Increase For NIH, 6.6% for NCI, In FY98 Appropriation

November 14, 1997

In Brief: Appelbaum Clinical Dib. At Hutchinson; Vogelstein Win Pezcoller Award; Curiel To UAB

July 23, 1993

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

In Brief: NCAB To Ponder Organ Systems Program Fate, Cancer Centers Issues, Hear Surveillance Review

January 29, 1988

Construction Funds Far Short Of NCA request; Terry Sees No Improvement

October 3, 1980

NCI Reponses To GAO On Eppley Contract Doesn’t Pull Any Punches

September 17, 1977